Microbiologist Dr Victoria Gordon is the co-founder and director of QBiotics Group, a pioneering medical research company specialising in transforming molecules from the Australian tropical rainforest into new medicines. 

Under her exceptional leadership as CEO for 24 years, QBiotics has become an internationally recognised leader in biodiscovery, successfully advancing groundbreaking treatments in oncology and wound healing. Gordon grew the company from humble beginnings in her basement to an established team of 58 with collaborations spanning major research institutions and key opinion leaders worldwide. Gordon, along with co-founder Dr Paul Reddell and their dedicated team, have built an impressive drug discovery pipeline, spanning preclinical investigations to human clinical trials and veterinary product registration. Their highly successful and unique discovery technology, EcoLogic™, combined with early real-world veterinary clinical data, supports selection of drug candidates with a high potential for successful development

Gordon has also made enduring contributions to policy, science education and governance through advisory roles. She provided critical expertise to the Queensland Biodiscovery Act 2004, considered a regulatory blueprint for aligning scientific innovation with sustainable and ethical use of biodiversity.

Victoria is the Co-Founder, CEO and Managing Director of the QBiotics Group. Over the last 25 years, Victoria demonstrated exceptional leadership, strategic vision, and scientific expertise. Under her guidance, the company has successfully advanced groundbreaking treatments in oncology and wound healing. The company has a marketed drug in the veterinary area, Stelfonta, and human clinical Phase l and Phase ll trials in oncology and wound healing. This success is rare for a small company and clearly demonstrate the drive and passion to commercialise Queensland’s natural resources in terms of compounds originating from plants. Victoria's contributions has been achieved via collaboration with the Queensland Government. The work undertaken in the QBiotics Group identifying drugs to address unmet medical needs, has demonstrated the significant value that lies in Queensland’s exceptional rainforests as a source of new medicines.